Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial

Conclusions
Our results suggest that methylprednisolone pulse could be an efficient therapeutic agent for hospitalised severe COVID-19 patients at the pulmonary phase.

Source: European Respiratory Journal - December 24, 2020 Category: Respiratory Medicine Authors: Edalatifard, M., Akhtari, M., Salehi, M., Naderi, Z., Jamshidi, A., Mostafaei, S., Najafizadeh, S. R., Farhadi, E., Jalili, N., Esfahani, M., Rahimi, B., Kazemzadeh, H., Mahmoodi Aliabadi, M., Ghazanfari, T., Sattarian, M., Ebrahimi Louyeh, H., Raeeskaram Tags: Respiratory infections and tuberculosis Original Articles: Infectious disease Source Type: research